Live Breaking News & Updates on நூற்றாண்டு ப்ரொஃபெஸர்

Stay updated with breaking news from நூற்றாண்டு ப்ரொஃபெஸர். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

M6P Therapeutics Presented Data on M041, A Recombinant Enzyme Therapy, for the Treatment of Sanfilippo B Syndrome at MPS 2021 | Proteins and Peptides



Leveraging the Company’s proprietary S1S3 bicistronic expression platform, M041 is co-expressed human NAGLU and S1S3, resulting in NAGLU
M6P –

With increased efficiency to phosphorylate lysosomal enzymes, M041 is a potential novel recombinant enzyme therapy for Sanfilippo B syndrome –
ST. LOUIS, MO, USA I July 28, 2021 IM6P Therapeutics (“M6PT” or “the Company”), a privately held life sciences company developing next-generation recombinant enzyme and gene therapies for lysosomal storage disorders (LSDs), today announced pre-clinical proof-of-concept data on M041 in a poster presentation by Patricia Dickson, M.D., Centennial Professor of Pediatrics and Chief, Division of Genetics and Genomic Medicine, Washington University of St. Louis, titled “ ....

Patricia Dickson , Pawel Krysiak , Washington University Of St , Division Of Genetics , International Symposium , Therapeutics Presented Data , Recombinant Enzyme Therapy , Sanfilippob Syndrome , United Statesi July , Centennial Professor , Genomic Medicine , Washington University , Annual International Symposium , Related Diseases , பாட்ரிசியா டிக்சன் , வாஷிங்டன் பல்கலைக்கழகம் ஆஃப் ஸ்டம்ப் , பிரிவு ஆஃப் ஜெநெடிக்ஸ் , சர்வதேச சிம்போசியம் , நூற்றாண்டு ப்ரொஃபெஸர் , வாஷிங்டன் பல்கலைக்கழகம் , ஆண்டு சர்வதேச சிம்போசியம் , தொடர்புடையது நோய்கள் ,